Current Notices in the Federal Register for Advisory Committee Nominations
Request for Nominations for Voting Members on a Public Advisory Committee; Blood Products Advisory Committee -- Nominations received on or before October 21, 2019 will be given first consideration for membership on the Blood Products Advisory Committee. Nominations received after October 21, 2019 will be considered for nomination to the committee as later vacancies occur. See FR notice for additional details.
Recent Change February 2017 -- New Process for Collecting and Posting Curricula Vitae
- Advisory Committee Nomination; Modification to Process for Collecting and Posting Curricula Vitae -- The Food and Drug Administration (FDA, Agency, or we) is modifying the process by which we collect and post curricula vitae (CVs) of advisory committee members so that the CV's will be posted to our Web site without removing or redacting any information. Posting CVs without removing or redacting any information will increase the transparency of FDA's selection of officials who serve on advisory committees, and will ensure greater public access to the qualifications of advisory committee members on an ongoing basis. All updated CVs for existing advisory committee members will be required to be submitted to FDA along with the required consent form after March 8, 2017. Click on the title above to see FR publication with full details on FDA modifying the process on the collection and postings of CV for advisory committee members.
- Proposed Collection; Comment Request; Collection of Nominations for Candidates To Serve on the Food and Drug Administration's Advisory Committees -- The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1955 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days (April 7, 2017) for public comments in response to the notice. This notice solicits comments on the Agency's process for collecting nomination of candidates to serve on FDA's advisory committee. Click on the title above to see FR publication with full details on how to comment on this proposed change.